logo conference-reports

Kongressrapporter

Educational funding by logo MSD Oncology

ESMO 2018 – Special symposium on balancing efficacy and toxicity in Hodgkin’s Lymphoma

Striking the right balance between efficacy and toxicity is crucial in all stages of Hodgkin’s Lymphoma and many promising agents/strategies are currently under investigation in different settings
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis